Lemonade, Inc. (NYSE:LMND – Get Free Report) Director Debra Schwartz sold 4,200 shares of Lemonade stock in a transaction on Thursday, December 11th. The shares were sold at an average price of $83.59, for a total transaction of $351,078.00. Following the completion of the transaction, the director owned 21,567 shares in the company, valued at approximately $1,802,785.53. This trade represents a 16.30% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link.
Lemonade Stock Performance
Lemonade stock traded down $2.69 during trading hours on Monday, reaching $75.16. 1,816,388 shares of the stock were exchanged, compared to its average volume of 2,440,583. Lemonade, Inc. has a 52-week low of $24.31 and a 52-week high of $84.52. The stock has a market cap of $5.62 billion, a P/E ratio of -31.45 and a beta of 2.12. The firm’s 50 day moving average is $65.71 and its 200 day moving average is $53.42.
Lemonade (NYSE:LMND – Get Free Report) last issued its quarterly earnings results on Wednesday, November 5th. The company reported ($0.51) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.72) by $0.21. The business had revenue of $194.50 million for the quarter, compared to analyst estimates of $185.06 million. Lemonade had a negative net margin of 26.39% and a negative return on equity of 31.86%. The business’s revenue was up 42.4% compared to the same quarter last year. During the same period in the previous year, the business posted ($0.95) earnings per share. Equities research analysts expect that Lemonade, Inc. will post -3.03 EPS for the current fiscal year.
Institutional Trading of Lemonade
Wall Street Analyst Weigh In
A number of equities analysts have recently issued reports on the company. Keefe, Bruyette & Woods increased their target price on Lemonade from $35.00 to $40.00 and gave the stock an “underperform” rating in a research note on Tuesday, November 25th. BMO Capital Markets upped their price objective on Lemonade from $23.00 to $42.00 and gave the stock an “underperform” rating in a report on Monday, August 18th. JMP Securities set a $80.00 target price on Lemonade in a report on Monday, November 24th. Piper Sandler decreased their price objective on shares of Lemonade from $60.00 to $55.00 and set a “neutral” rating on the stock in a report on Friday, October 10th. Finally, Morgan Stanley raised their price objective on Lemonade from $49.00 to $53.00 and gave the company an “underweight” rating in a research note on Monday, November 17th. One equities research analyst has rated the stock with a Strong Buy rating, two have issued a Buy rating, one has assigned a Hold rating and four have assigned a Sell rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Hold” and an average target price of $58.57.
Read Our Latest Report on LMND
Lemonade Company Profile
Lemonade, Inc provides various insurance products through various channels in the United States, Europe, and the United Kingdom. Its insurance products include stolen or damaged property, and personal liability that protects its customers if they are responsible for an accident or damage to another person or their property.
Featured Articles
- Five stocks we like better than Lemonade
- Growth Stocks: What They Are, What They Are Not
- Why DLocal Is the Top Emerging Market Fintech Stock to Watch for 2026
- ESG Stocks, What Investors Should Know
- Is Nutanix the Best Comeback Trade Left in 2025? The Setup Says Yes
- 3 Grocery Stocks That Can Help Take a Bite Out of Inflation
- The Vertiv Pullback: Ignore the Noise, Buy the Data
Receive News & Ratings for Lemonade Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lemonade and related companies with MarketBeat.com's FREE daily email newsletter.
